"Hexamethonium" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
| Descriptor ID |
D018738
|
| MeSH Number(s) |
D02.092.877.250.592.400 D02.675.276.558.592.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hexamethonium".
Below are MeSH descriptors whose meaning is more specific than "Hexamethonium".
This graph shows the total number of publications written about "Hexamethonium" by people in this website by year, and whether "Hexamethonium" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hexamethonium" by people in Profiles.
-
Mechanisms of sustained cutaneous vasodilation induced by spinal cord stimulation. Auton Neurosci. 2004 Jul 30; 114(1-2):55-60.
-
Local cooling alters neural mechanisms producing changes in peripheral blood flow by spinal cord stimulation. Auton Neurosci. 2003 Mar 28; 104(2):117-27.
-
Low intensity spinal cord stimulation may induce cutaneous vasodilation via CGRP release. Brain Res. 2001 Mar 30; 896(1-2):183-7.